Skip to main content

Talasaz AmirAli's Form 4 filing

Guardant Health, Inc. (GH) · filed Mar 15, 2023

Accession no.
0001576280-23-000038
Filed
Mar 15, 2023
Trade date
Mar 13-14, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 9 non-derivative transactions. Open-market purchases total $2.50M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Talasaz AmirAliCIK 0001753159Director, Officer (Co-Chief Executive Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 13, 2023COMMON STOCKPPurchaseAcquired+12,187$24.78F1+$301,993.861,866,032Direct
Mar 13, 2023COMMON STOCKPPurchaseAcquired+27,813$26.04F2+$724,250.521,893,845Direct
Mar 13, 2023COMMON STOCKPPurchaseAcquired+6,094$24.78F1+$151,009.326,094Indirect
Mar 13, 2023COMMON STOCKPPurchaseAcquired+13,906$26.04F2+$362,112.2420,000Indirect
Mar 13, 2023COMMON STOCKPPurchaseAcquired+6,094$24.78F1+$151,009.326,094Indirect
Mar 13, 2023COMMON STOCKPPurchaseAcquired+13,906$26.04F2+$362,112.2420,000Indirect
Mar 14, 2023COMMON STOCKPPurchaseAcquired+8,500$26.40F3+$224,4001,902,345Direct
Mar 14, 2023COMMON STOCKPPurchaseAcquired+4,250$26.40F3+$112,20024,250Indirect
Mar 14, 2023COMMON STOCKPPurchaseAcquired+4,250$26.40F3+$112,20024,250Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Represents the weighted average price of shares purchased at prices that ranged from $24.65 to $25.00.

Referenced by the price of 3 transactions in Table I.

F2

Represents the weighted average price of shares purchased at prices that ranged from $25.965 to $26.20.

Referenced by the price of 3 transactions in Table I.

F3

Represents the weighted average price of shares purchased at prices that ranged from $26.00 to $26.58.

Referenced by the price of 3 transactions in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)